We are actively tracking the number of publications by the scientific community which reference our structures, whether in the main text, figure captions or supplementary material. Selected articles are manually reviewed. Publications by SSGCID authors are excluded from the manually reviewed list. From our manual curation results, we estimate that the false positive rate might be as high as 50% for some structures.
This list was obtained from Google Scholar searches using an API provided by Christian Kreibich.
| Structure | Year released | #citations |
|---|---|---|
| 3GK3 | 2009 | 1 |
| 3TL6 | 2011 | 1 |
| 5IFY | 2016 | 1 |
| 6OMZ | 2019 | 1 |
| 6W14 | 2020 | 1 |
| 6MQH | 2018 | 1 |
| 3GNN | 2009 | 1 |
| 6OVI | 2019 | 1 |
| 6CKQ | 2018 | 1 |
| 3GVC | 2009 | 1 |
| # | PDB | Additional SSGCID structures cited | Link | Title | Year | Citation | Highlighted abstract |
|---|---|---|---|---|---|---|---|
| 1 | 6mc0 | - | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4655406 | Synthesis and Kinetic Evaluation of Phosphomimetic Inhibitors Targeting Type B Ribose-5-Phosphate Isomerase from Mycobacterium Tuberculosis | 2023 | S Courtiol-Legourd, S Mariano, J Foret- Mycobacterium - papers.ssrn.com | of SoRpiA has not yet been presented, but that of the chloroplastic enzyme ( PDB code 6ZXT) [ An RpiA structure with R5P/Ru5P bound and with excellent resolution is 6MC0 (Legionella |
| 2 | 3o0m | 3oj7 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5273447 | Biochemical and Biophysical Characterization, and 3d Structure Modeling of Human Hint3, a Hydrolase of the Hit Superfamily | 2025 | R Dolot, M Sirerant, A Mikoajczyk- Available at SSRN - papers.ssrn.com | Structure modelling of the HINT3 (Gly36) variant revealed that the enzyme exists mainly in absent in the structures of HINT1 and HINT2. Analysis of the HINT3 structure shows that there... In a first attempt, a homology model for HINT3 was generated based on eight crystallographic structures with the PDB IDs: 5UVM, 6D6J, 6CVS, 3OJ7, 3O0M, 4INC, 3TW2, and 3O1Z (see Table S2) using the MODELLER 10.5 software. |
| 3 | 4g5d | - | https://parasitesandvectors.biomedcentral.com/track/pdf/10.1186/s13071-020-3883-... | Leishmania braziliensis prostaglandin F | 2020 | EVC AlvesFerreira, TR Ferreira, P Walrad - 2020 - parasitesandvectors.biomedcentral | 1b) and the 3D structure (Fig c 3D sequence alignments of protein sequences of LmjPGF2S (PBD ID 4G5D , in grey) and human ortholog share 51.4% similarity and 34.3% identity, modelling using the Research Collabora- tory for Structural Bioinformatics (RCSB) PDB suggests |
| 4 | 4efi | - | https://patents.google.com/patent/US20160201095A1/en | Methods for the site-selective introduction of halogen into natural products | 2016 | MCY Chang, MC Walker, BW Thuronyi- US Patent App. 14/913,601, 2016 - Google Patents | domain. The NphT7 structure was predicted using Phyre2 (Kelley, et al., Nat. Prot., 4:363-371 (2009)) and based on a type III 3-oxoacyl-(acyl-carrier protein) synthase from Burkholderia xenovorans ( PDB ID 4EFI ). Despite |
| 5 | 3tzs | - | https://patents.google.com/patent/US20160282341A1/en | Plasmonic biosensors with built-in artificial antibodies | 2016 | S Singamaneni, L Tian, KK Liu, A Abbas- US Patent App. 15, 2016 - Google Patents | organic silane monomers are functionalized prior to polymerizing the functional monomers onto the template molecule-nanostructure core structure 6.8, MW=64.5 kDa) or 0.5 mg/mL recombinant human neutrophil gelatinase-associated lipocalin (NGAL; pdb ID: 3TZS , Ip=8.9 |
| 6 | 3lgj | 3pgz | https://patents.google.com/patent/US20180179500A1/en | Modified enzymes | 2018 | AJ Heron, RV Bowen, M Bruce- US Patent App. 15, 2018 - Google Patents | In order to assess whether a suitable protein structure exists to use as a template to build a protein model, a search is performed on the protein data bank ( PDB ) database The sequence alignment and template structure are then used to produce a structural model of the The polynucleotide binding motif may be selected from any of those shown in Table 5 below. Bartonella 3LGJ, Q6G302 homo-tetramer |
| 7 | 4ot8 | - | https://patents.google.com/patent/US20180265905A1/en | Chemoenzymatic synthesis of peptide beta-lactones and beta-hydroxy acids | 2018 | TA Wencewicz, JE Schaffer, MR Reck- US Patent App. 15/921,442, 2018 - Google Patents | Although the biological target of RC-Obi is unknown, bacterial transpeptidases are thought to be potential targets due to the structural similarity of RC-Obi to monocyclic -lactam antibiotics and the FIG. 14D is an X-ray crystal structure of the EntF TE domain ( PDB 3TEJ). FIG |
| 8 | 4dxl | - | https://patents.google.com/patent/US20180271098A1/en | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | 2018 | TJ Hagen, M Thompson, JR Troxell- US Patent App. 15, 2018 - Google Patents | To date, there are 17 crystal structures of six different species of IspE deposited in the PDB with 17 different ligands FIG. 11 . X-Ray Crystal Structure of Mycobacterium abscessus IspE with ATP (red) and CMP (blue) Bound to Active Site; PDBID 4DXL . FIG. 12 |
| 9 | 3oa3 | 3ndo, 3ngj | https://patents.google.com/patent/US20180340193A1/en | Methods And Microorganisms For The Production Of 1, 3-Butanediol | 2018 | R Mahadevan, A Yakunin, P Gawand- US Patent App. 15, 2018 - Google Patents | 2.4.). In some embodiments, DERA enzymes can be described as class I aldolases that form covalent Schiff base intermediates. In all studied structures , DERA adopts the classical eight-bladed TIM barrel fold. The oligomerisation |
| 10 | 5vwm | - | https://pdfs.semanticscholar.org/1774/b2148932698ea43fe239489547556ff273f3.pdf | In silico study of various compounds from essential oil of Cymbopogon winterianus against Pseudomonas aeruginosa targets | 2019 | Moura, A Monteiro, M Maia, N Sousa, G Rodrigues - 2019 - pdfs.semanticscholar.org | Protein resolution values were 2.1 for ExoA ( PDB ID 1XK9), 1.8 for LpxC ( PDB ID 5VWM ) and 2.31 for PBP3 ( PDB ID 4KQO). All presented inhibitors coupled to their crystallographic structure , which allowed the delimitation of the active site of each protein |